IRIS
PEROSA, Federico
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.039
EU - Europa 2.245
AS - Asia 1.130
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 7
AF - Africa 4
SA - Sud America 1
Totale 11.433
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.027
CN - Cina 750
IT - Italia 547
SE - Svezia 510
UA - Ucraina 396
SG - Singapore 306
DE - Germania 289
FI - Finlandia 202
GB - Regno Unito 133
FR - Francia 65
IN - India 37
IE - Irlanda 31
BE - Belgio 24
VN - Vietnam 16
PL - Polonia 13
CA - Canada 9
EU - Europa 7
IR - Iran 7
AU - Australia 6
HR - Croazia 6
NL - Olanda 6
TR - Turchia 4
AT - Austria 3
ID - Indonesia 3
MA - Marocco 3
AZ - Azerbaigian 2
CH - Svizzera 2
DK - Danimarca 2
ES - Italia 2
MD - Moldavia 2
MX - Messico 2
RU - Federazione Russa 2
AL - Albania 1
BG - Bulgaria 1
BZ - Belize 1
CZ - Repubblica Ceca 1
GR - Grecia 1
IM - Isola di Man 1
JP - Giappone 1
KH - Cambogia 1
LT - Lituania 1
ME - Montenegro 1
MK - Macedonia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
OM - Oman 1
PE - Perù 1
PK - Pakistan 1
PT - Portogallo 1
RO - Romania 1
TH - Thailandia 1
Totale 11.433
Salva come PNG Salva come JPEG
Città #
Jacksonville 940
Chandler 927
Fairfield 860
Woodbridge 666
Houston 521
Ashburn 519
Ann Arbor 396
Nyköping 377
Cambridge 355
Seattle 349
Wilmington 324
Bari 269
Singapore 235
Nanjing 202
Lawrence 200
Roxbury 200
Beijing 136
Des Moines 133
Boardman 129
New York 113
Princeton 90
Inglewood 66
Nanchang 57
Shenyang 52
Hebei 48
San Diego 40
Brooklyn 37
Santa Clara 37
Pune 33
Jiaxing 32
Los Angeles 32
Tianjin 28
Changsha 26
London 25
Brussels 24
Dublin 24
Guangzhou 20
Noicattaro 19
Paris 18
Dong Ket 16
Dearborn 15
Rome 15
Falls Church 14
Grafing 14
Marseille 14
Washington 13
Auburn Hills 12
Radomsko 12
Helsinki 10
Munich 9
Milan 8
Norwalk 8
Redwood City 8
Ardabil 7
Hefei 7
Jinan 7
Leawood 7
Ningbo 7
Indiana 6
Kilburn 6
Kunming 6
San Francisco 6
Sydney 6
Wuhan 6
Frankfurt am Main 5
San Mateo 5
Taizhou 5
Zhengzhou 5
Amsterdam 4
Chiswick 4
Florence 4
Naples 4
Redmond 4
Triggiano 4
Yiwu 4
Aci Castello 3
Augusta 3
Chicago 3
Chongqing 3
Great Yarmouth 3
Jinhua 3
Martina Franca 3
Monmouth Junction 3
Mugla 3
Napoli 3
Padova 3
Pescara 3
Phoenix 3
Prescot 3
Romola 3
Toronto 3
Waterford 3
Wuxi 3
Acquaviva Picena 2
Arzano 2
Bologna 2
Canosa Di Puglia 2
Catanzaro 2
Centro 2
Copenhagen 2
Totale 8.914
Salva come PNG Salva come JPEG
Nome #
Evaluation of the influence of social, demographic, environmental, work-related factors and/or lifestyle habits on Raynaud's phenomenon: a case-control study 139
Anti-carbamylated protein antibodies and skin involvement in patients with systemic sclerosis: An intriguing association 123
CD20-Mimotope Peptides: A Model to Define the Molecular Basis of Epitope Spreading 123
Clinical correlates of human leucocyte antigen (HLA)-G in systemic sclerosis 121
Antibody V(h) repertoire differences between resolving and chronically evolving hepatitis C virus infections 119
Anti-centromere protein A antibodies in systemic sclerosis: Significance and origin 116
Autoantibodies Recognizing the Amino Terminal 1-17 Segment of CENP-A Display Unique Specificities in Systemic Sclerosis 113
CD20-depleting therapy in autoimmune diseases: from basic research to the clinic 107
Alterations in the antigen processing-presenting machinery of transformed plasma cells are associated with reduced recognition by CD8+ T cells and characterize the progression of MGUS to multiple myeloma 106
Clinical correlates of a subset of anti-CENP-A antibodies cross-reacting with FOXE3p53-62 in systemic sclerosis 105
Oxidized low density lipoproteins: The bridge between atherosclerosis and autoimmunity. Possible implications in accelerated atherosclerosis and for immune intervention in autoimmune rheumatic disorders. 105
Serum levels of beta-2-microglobulin-free heavy chain of HLA class I antigen in healthy individuals: relationship to their class I allotype 104
CD20-Mimotope Peptide Active Immunotherapy in Systemic Lupus Erythematosus and a Reappraisal of Vaccination Strategies in Rheumatic Diseases 103
Autoantibodies to intracellular antigens: generation and pathogenetic role 102
Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma 101
AB0695 Subspecificities of Anti-Centromeric-Associated Protein a (CENP-A) Antibodies (AB) Can Identified a Subset of Patients at Higher Risk of Developing Pulmonary Hypertension 96
MHC Class i Antigen Processing and Presenting Machinery: Organization, Function, and Defects in Tumor Cells 96
Subspecificities of anticentromeric protein A antibodies identify systemic sclerosis patients at higher risk of pulmonary vascular disease 94
Vasculitides: Proposal for an integrated nomenclature 91
Cinetica di produzione e clonotipia di anticorpi anti-anti-idiotipo (Ac3) in due pazienti affette da patologia autoimmune immunizzate con un anticorpo monoclonale anti-idiotipo (AcMo2) 90
Absence of streptococcal protein G (PG)-specific determinant in the Fab region of human IgG2 89
Preparation, characterization and utilization of monoclonal antibodies to the gene products of the HLA-D region with special emphasis on those to polymorphic determinants 89
Serological methods to detect anti-idiotypic antibodies 89
CD20 mimicry by a mAb rituximab-specific linear peptide: A potential tool for active immunotherapy of autoimmune diseases 89
Generation of biologically active linear and cyclic peptides has revealed a unique fine specificity of rituximab and its possible cross-reactivity with acid sphingomyelinase-like phosphodiesterase 3b precursor 86
CD20: A target antigen for immunotherapy of autoimmune diseases 86
Working and safety profiles of JAK/STAT signaling inhibitors. Are these small molecules also smart? 86
Rheumatic disorders as paraneoplastic syndromes 85
Extra-articular manifestations of rheumatoid arthritis: an update 85
Human CD4 internal antigen anti-idiotypic monoclonal antibody. Immunochemical and sequence analysis 83
Alterations in the antigen processing-presenting machinery of transformed plasma cells are associated with reduced recognition by CD8+ T cells and characterize the progression of MGUS to multiple myeloma 83
The Fab region of IgG2 human myeloma proteins does not bear the streptococcal protein G-specific determinant 82
The immunodominant epitope of centromere-associated protein A displays homology with the transcription factor forkhead box E3 (FOXE3) 81
null 81
Effects of Adjuvants for Human Use in Systemic Lupus Erythematosus (Sle)-Prone (Nzb/Nzw) F1 Mice 80
CD20 mimicry by mAb Rituximab-specific linear peptide. A potential tool for active immunotherapy of autoimmune diseases 80
Macrophage activation syndrome in patients affected by adult-onset still disease: Analysis of survival rates and predictive factors in the Gruppo Italiano di Ricerca in reumatologia clinica e sperimentale cohort 80
Evaluation of biotinylated cells as a source of antigens for characterization of their molecular profile 79
Two structurally different rituximab-specific CD20 mimotope peptides reveal that rituximab recognizes two different CD20-associated epitopes 79
Personalized medicine in rheumatoid arthritis: How immunogenicity impacts use of TNF inhibitors 78
Size variants of beta-2-microglobulin-free human leucocyte antigen class I heavy chain make different contributions to its serum increase in multiple myeloma 77
null 77
Syngeneic antiidiotypic monoclonal antibodies to the murine anti-HLA- DR,DP monoclonal antibody CR11-462 76
null 76
Increased serum levels of beta2m-free HLA class I heavy chain in multiple myeloma 75
Murine antiidiotypic monoclonal antibodies that bear the internal image of HLA-DR allospecificities 74
A sandwich assay to detect and characterize syngeneic anti-idiotypic antibodies to murine anti-HLA and tumor associated antigen monoclonal antibodies 74
Biological therapy with monoclonal antibodies: a novel treatment approach to autoimmune disease 73
B2 microglobulin-free heavy chain (FHC) of HLA class I antigen in patients with Hodgkin’s and non Hodgkin’s lymphomas 71
Antiphospholipids syndrome complicated by a systemic capillary leak-like syndrome treated with steroids and intravenous immunoglobulins a case report 71
Immunochemical and functional characterization of anti-idiotypic antibodies to a mouse anti-CD4 monoclonal antibody 71
Response to "Is active acid sphingomyelinase required for the antiproliferative response to rituximab?" [e-letter]. http://bloodjournal.hematologylibrary.org/content/117/13/3695.citation/reply#bloodjournal_el_2268 69
Amyloidosis: clinical picture, immunological and biomolecular features, treatment prospects 69
Low mortality rate in Italian rheumatoid arthritis patients from a tertiary center: Putative implication of a low anti-carbamylated protein antibodies prevalence 69
Purification of human immunoglobulins by sequential precipitation with caprylic acid and ammonium sulphate 68
Identification of an antigenic and immunogenic motif expressed by two 7-mer rituximab-specific cyclic peptide mimotopes: Implication for peptide-based active immunotherapy 67
Anti-carbamylated protein antibodies in patients with systemic sclerosis: an intriguing association with skin involvement 67
Soluble CD4 antigen reactivity in intravenous immunoglobulin preparations: is it specific? 67
Prescribing motivations and patients’ characteristics related to the use of biologic drugs in adult-onset Still’s disease: analysis of a multicentre “real-life” cohort 66
Severe pulmonary hypertension as the initial manifestation of systemic lupus erythematosus: a case report and review of the literature 65
Identification of an antigenic and immunogenic motif expressed by two 7-Mer Rituximab-specific cyclic peptides 64
Anti-idiotypic monoclonal antibodies (mAb) to an anti-CD4 mAb induce CD4+ T cell depletion in rabbit 64
B-T cell interaction in the pathogenesis of HCV-positive mixed cryoglobulinemia. 64
Beta2-m-free heavy chain levels of HLA-class I antigen combined with serum IgM or platelet count provide two reliable staging systems in multiple myeloma 62
Analisi molecolare di un anticorpo monoclonale (ACMO) anti-idiotipo 'immagine interna' dell'antigene CD4 62
Fine specificity and idiotype diversity of the murine anti-HLA-A2, A28 monoclonal antibodies CR11-351 and KS1 62
Amyloidosis: clinical picture, immunological and biomolecular features, treatment prospects 61
Syngeneic polyclonal and monoclonal antiidiotypic antibodies to murine anti-human high molecular weight-melanoma associated antigen and anti-HLA monoclonal antibodies 61
Purification of murine IgG monoclonal antibodies by precipitation with caprylic acid: comparison with other methods of purification 61
Beta2-microglobulin-free HLA class I heavy chain epitope mimicry by monoclonal antibody HC-10-specific peptide 60
L'AMILOIDOSI: QUADRI CLINICI, CARATTERISTICHE IMMUNOLOGICHE E BIOMOLECOLARI, PROSPETTIVE TERAPEUTICHE 60
Antigenic mimicry by linear peptides of the conformational epitope recognized by the anti-CD20 monoclonal antibody (mAb) Rituximab 59
Identificazione del peptide che mima l'epitopo localizzato sulla catena pesante HLA-I non associata alla beta 2-microglobulina, riconosciuto dall'anticorpo monoclonale HC-10 58
Cinetica di produzione e clonotipia di anticorpi anti-anti-idiotipo (Ac3) in due pazienti affetti da patologia autoimmune, immunizzati con un anticorpo monoclonale anti-idiotipo (AcMo2) "Immagine Interna" dell'antigene CD4 58
Antiidiotype to anti-CD4 monoclonal antibody (mAb) as surrogate of human CD4 antigen (Ag) for active immunotherapy in autoimmune diseases 58
SARS-CoV-2 infection complicated by inflammatory syndrome. Could high-dose human immunoglobulin for intravenous use (IVIG) be beneficial? 58
Studi in vitro dell'attivita' antiallergica del Fenoterolo 57
EXPRESSION OF THE TRANSCRIPTION FACTOR FORKHEAD BOX E3 (FOXE3) IN PERIPHERAL BLOOD MONONUCLEAR CELLS OF PATIENTS WITH SYSTEMIC SCLEROSIS 57
Alternative splicing of HLA-C mRNA in HCV-infected hepatocytes reduces viral epitope-specific cytotoxicity T cell response and promotes NK activity 57
Staging multiple myeloma patients with active disease using serum levels of beta2m-free HLA class I heavy chain together with IgM or platelet count 56
Anticorpi monoclonali anti-idiotipo (Ab2) anti-CD4 inducono anticorpi anti-CD4 in un sistema singenico 56
Anticorpi anti-DNA e network idiotipico nel LES: recenti progressi e prospettive terapeutiche 56
Human CD4 mimicry by anti-idiotypic monoclonal antibody 16D7 is based on a conformational epitope 56
Sars-cov-2 inflammatory syndrome. Clinical features and rationale for immunological treatment 56
Syngeneic anti-idiotypic antisera to murine monoclonal antibodies to monomorphic and polymorphic determinants of HLA class I antigens 55
Vaccination against CD20 mimotope peptiide. Is it a feasible strategy for the treatment of autoimmune diseases? 55
Antigene CD4 solubile nei preparati di immunoglobuline umane per vie endovenosa 55
Anticorpi singenici poli e monoclonali anti-idiotipo (Ab2) specifici per un AcMo murino anti-CD4 HP2/6 55
Analysis of beta-2 microglobulin (b2M), free HLA class I heavy chain (FHC) and the associated protein pattern in multiple myeloma (MM) patients from the Nordic Myeloma Group Study #5/94. Haematologica-the Hematology Journal 55
Syngeneic anti-idiotipyc monoclonal antibodies that bear the internal image of HLA-DR antigen 54
Human CD4 "internal antigen" mimicry by anti-idiotypic monoclonal antibodies 54
Involvement of FAB subclass-specific determinants in the interaction of human IgG with Streptococcal Protein (PG) 53
The proliferative transcriptional factor FOXE3 is the target of anti-CENP-A antibodies and identifies a subset of anti-CENP antibody positive systemic sclerosis patients 53
Syngeneic antiidiotypic monoclonal antibodies to murine anti human high molecular weight-melanoma associated antigen monoclonal antibodies 53
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management 52
Vasculiti primarie sistemiche 52
Mieloma multiplo e gammapatie monoclonali: quadri clinici, acquisizioni eziopatogenetiche e progressi terapeutici 51
Subclinical atherosclerosis and history of cardiovascular events in Italian patients with rheumatoid arthritis: Results from a cross-sectional, multicenter GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study 51
Minimum structural requirement for CD4 mimicry by anti-idiotipic mAb 16D7 51
Anticorpi monoclonali nell'immunoterapia delle malattie autoimmuni 50
Totale 7.518
Salva come PNG Salva come JPEG
Categoria #
all - tutte 52.097
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.097
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.593 0 0 0 0 305 150 265 141 294 125 277 36
2020/20211.905 214 42 203 63 256 95 261 110 228 220 133 80
2021/20221.423 63 214 8 80 77 71 110 87 64 42 236 371
2022/20232.317 340 204 114 226 323 333 36 264 361 28 52 36
2023/2024860 64 143 43 91 65 221 25 66 6 16 39 81
2024/2025626 99 48 336 80 63 0 0 0 0 0 0 0
Totale 11.791